A pattern, and a collective of butterflies.
The Kaleidoscope is EBRPA's community of donors — a collective of contributions, large and small, transforming giving into shared commitment for people living with Epidermolysis Bullosa.
Three tiers. A three-year horizon. A way of backing the science with the discipline of an investor and the patience of a partner.
Find your place Learn moreLet's be honest about what's happening here.
If you're reading this anywhere near the end of financial year, you are almost certainly being asked for money by everyone else right now. We know. We see the same inbox you do.
So we're going to do this a little differently.
EBRPA has never really been a "give now" sort of organisation. We are a venture philanthropy fund. We invest in EB research strategically, over years, with the discipline of an investor rather than the urgency of an appeal. That long game is the entire point of us — it is why two of the three approved EB treatments in the world today exist.
And it is why the Kaleidoscope is not a campaign. It is a community: a structure built for the people who want to back this work over time, on terms that match how the work actually unfolds.
If you're here, you're probably the kind of person we built it for. Welcome.
Three layers, forming one pattern.
The EB community — at the centre.
Everything starts here. EB is a family of conditions — simplex, dystrophic, junctional, Kindler — affecting people of every age, in different ways, with different needs. Children for whom a hug is a wound. Adults navigating chronic pain. Families carrying both the science and the daily weight of care. Their fragility is real. So is their strength. They are the heart of the Kaleidoscope, and the reason every other ring exists.
The donors — holding the ring.
Around the EB community sits the second ring — the donors who enable, support, and sustain the work. Whether your contribution is small or significant, the Kaleidoscope holds it equally. A monthly gift at Wings is a fragment. So is a major partnership at EverBrave. Both belong to the same pattern, and neither is complete without the other.
Researchers, industry & advocacy partners — shifting the whole thing.
The outer ring is where the pattern moves outward into the world. Scientists pursuing gene therapy, protein replacement, regenerative medicine, pain and itch. Industry partners building the manufacturing and commercialisation pathways no charity could build alone. Advocacy partners shifting policy, regulation and access. Two of the three FDA-approved EB treatments now in existence began as projects EBRPA backed. That is the pattern shifting in real time.
Three tiers. Two ways to give.
Each tier reflects a different commitment level — and a different depth of partnership with EBRPA's research. Choose where you would like to begin. You can move between tiers at any time.
Wings members are the foundation of the Kaleidoscope — individuals who have made a conscious decision to back EB research with sustained capital.
Join at WingsHorizon members directly accelerate EBRPA's capacity to identify and fund new research opportunities. Deeper engagement with our research pipeline.
Join at HorizonEverBrave members are partners in EBRPA's mission: engaged in strategy, connected to researchers, and recognised as the driving force behind our most significant breakthroughs.
Join at EverBraveYou'll create a quick account at the donate step so you can manage your giving anytime — change tier, update card, pause if you ever need to.
A planning horizon, not a contract.
Membership of the Kaleidoscope is a three-year commitment. This is not incidental. In venture philanthropy, meaningful research outcomes require sustained investment — both financial and relational.
A three-year partnership allows EBRPA to plan with confidence, researchers to work without interruption, and you to see the arc of your investment unfold in real time.
We don't lock you in legally — life changes, and so do circumstances. The commitment is a planning horizon, not a contract. What we ask is intention; what we promise in return is that we will spend that horizon worth your trust.
Discipline, not just good intentions.
EBRPA operates as a venture philanthropy fund — one of very few in the rare disease space. That means we don't pool donations and disperse them. We invest them: strategically, into the world's most promising EB research, with milestone tracking, due diligence and accountability built in.
And when funded research reaches commercial therapy, we retain a financial upside that is reinvested entirely into further EB research. Capital recycles. Every dollar of return funds the next breakthrough.
Recognised by Harvard, Yale and the Milken Institute FasterCures as an exemplar for rare disease philanthropy. Typically more than 90% of revenue flows directly to research and programs — a figure that reached 100% in late 2025, made possible by two private donors covering all operating costs.
Things worth asking up front.
Find your place in the Kaleidoscope.
Three tiers. A three-year horizon. A community of people who back rare disease research with patience, discipline, and a refusal to accept that things have to stay the way they are.
Choose your tier → Or email Simone first to talk it through